Skip to main content

Advertisement

SpringerLink
Log in

Infratentorial posterior reversible encephalopathy syndrome in INFβ1a-treated multiple sclerosis patient

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Data availability

All data needed to evaluate the conclusions are present in the paper. Additional data related to this paper may be requested from the corresponding Author, upon reasonable request by qualified academic investigators.

References

  1. Hinchey J et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334(8):494–500

    Article  CAS  PubMed  Google Scholar 

  2. Fugate JE, Rabinstein AA (2015) Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 14(9):914–925

    Article  PubMed  Google Scholar 

  3. Wijburg MT et al (2021) Pharmacovigilance during treatment of multiple sclerosis: early recognition of CNS complications. J Neurol Neurosurg Psychiatry 92(2):177–188

    Article  PubMed  Google Scholar 

  4. Nishio H et al (2016) Thrombotic microangiopathy caused by interferon β-1b for multiple sclerosis: a case report. CEN Case Rep 5:179–183

    Article  PubMed  PubMed Central  Google Scholar 

  5. Mastorodemos VC et al (2020) Posterior Reversible Encephalopathy Syndrome, Multiple Sclerosis and interferon therapy: Association, co-incidence or convoluted interplay? Mult Scler Relat Disord 45:102356

    Article  PubMed  Google Scholar 

  6. Dietz N et al (2021) Acute posterior reversible encephalopathy syndrome (PRES) in setting of interferon-beta use: case presentation with reduction of edema in 72 h after cessation of interferon-beta therapy with sub-clinical inflammation. BMC Neurol 21:1–5

    Article  Google Scholar 

  7. Kraus J, Oschmann P (2006) The impact of interferon-β treatment on the blood–brain barrier. Drug Discov Today 11(15–16):755–762

    Article  CAS  PubMed  Google Scholar 

  8. Ledinek A et al (2009) Pulmonary arterial hypertension associated with interferon beta treatment for multiple sclerosis: a case report. Mult Scler J 15(7):885–886

    Article  CAS  Google Scholar 

  9. Ou S et al (2018) Posterior reversible encephalopathy syndrome with isolated involving infratentorial structures. Front Neurol 9:843

    Article  PubMed  PubMed Central  Google Scholar 

  10. Fitzgerald RT et al (2015) Features of infratentorial-predominant posterior reversible encephalopathy syndrome. Acta Neurol Belg 115:629–634

    Article  PubMed  PubMed Central  Google Scholar 

  11. Lindå H, von Heijne A (2015) A case of posterior reversible encephalopathy syndrome associated with Gilenya®(fingolimod) treatment for multiple sclerosis. Front Neurol 6:39

    Article  PubMed  PubMed Central  Google Scholar 

  12. Cohen JA et al (2019) Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial. Lancet Neurol 18(11):1021–1033

    Article  CAS  PubMed  Google Scholar 

  13. Décard BF et al (2013) Natalizumab-associated reversible encephalopathy syndrome mimicking progressive multifocal leukoencephalopathy. Mult Scler J 19(2):249–251

    Article  Google Scholar 

  14. Berger JR et al (2014) Posterior reversible encephalopathy syndrome masquerading as progressive multifocal leukoencephalopathy in rituximab treated neuromyelitis optica. Mult Scler Relat Disord 3(6):728–731

    Article  PubMed  Google Scholar 

  15. Morrow SA et al (2015) Posterior reversible encephalopathy syndrome due to high dose corticosteroids for an MS relapse. Case Rep Neurol Med 2015:325657

  16. Cooksley T, Haji-Michael P (2011) Posterior reversible encephalopathy syndrome associated with deoxycoformycin and alemtuzumab. J R Coll Physicians Edinb 41(3):215–217

  17. Snehal I (2023) Delayed Malignant Cerebellar Posterior Reversible Encephalopathy Syndrome secondary to CLAG-M and Venetoclax regimen. Graduate Medical Education Research Journal 5(1). https://digitalcommons.unmc.edu/gmerj/vol5/iss1/70

Download references

Funding

The present work did not receive any funding.

Author information

Author notes

  1. Gianni Cutillo and Martina Rubin contributed equally to the present work.

Authors and Affiliations

  1. Neurology Unit, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy

    Gianni Cutillo, Martina Rubin, Giulia d’Amore, Massimo Malcangi, Vittorio Martinelli, Federica Esposito & Massimo Filippi

  2. Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy

    Gianni Cutillo, Giulia d’Amore & Massimo Filippi

  3. Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy

    Martina Rubin & Massimo Filippi

  4. Laboratory of Human Genetics of Neurological Disorders, Division of Neuroscience, Institute of Experimental Neurology, IRCCS San Raffaele Scientific Institute, Milan, Italy

    Laura Ferrè & Federica Esposito

  5. Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy

    Laura Ferrè & Massimo Filippi

  6. Neuroradiology Unit and High Field MRI Center, IRCCS San Raffaele Scientific Institute, Milan, Italy

    Paolo Q. Vezzulli

  7. Vita-Salute San Raffaele University, Milan, Italy

    Gianni Cutillo, Martina Rubin, Giulia d’Amore, Massimo Malcangi & Massimo Filippi

Authors
  1. Gianni Cutillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martina Rubin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giulia d’Amore
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Massimo Malcangi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Paolo Q. Vezzulli
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Laura Ferrè
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Vittorio Martinelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Federica Esposito
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Massimo Filippi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Massimo Filippi.

Ethics declarations

Conflicts of interest

The authors have no disclosures related to the present work.

Ethical and informed consent statement

The present study was conducted in accordance to the Helsinki Declaration (Fortaleza revision, 2013) and with European and Italian regulations about privacy. Informed consent was obtained from the patient.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cutillo, G., Rubin, M., d’Amore, G. et al. Infratentorial posterior reversible encephalopathy syndrome in INFβ1a-treated multiple sclerosis patient. J Neurol 271, 2225–2229 (2024). https://doi.org/10.1007/s00415-024-12226-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-024-12226-2

Search

Navigation